Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-05 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-05 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-05 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.0002 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |